Clinical Trial Update: Immunotherapy With Neo-adjuvant Chemotherapy for OVarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluated immunotherapy with neo-adjuvant chemotherapy for ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED